OrthoTrophix, Inc.
PrivateLast Round
VC Round
Dec 16, 2016
Company Overview
OrthoTrophix, Inc. operates in Healthcare & Life Sciences and is based in Foster City, California. Its latest recorded funding round was a VC Round in December 2016.
OrthoTrophix, Inc. is a biopharmaceutical company that develops and commercializes disease-modifying osteoarthritis drugs and therapies for hard tissue conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OrthoTrophix, Inc. Comparables
Compare OrthoTrophix, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Symic Bio | 87% | |
| Genascence Corporation | 86% | |
| Cytonics Corporation | 86% |
For institutional investors. Book with your work email.
OrthoTrophix, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 16, 2016 | ||||
| Series A | Jan 1, 2014 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 77% MoM.
- May 1, 2025
Monthly visitors increased 54% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withNov 9, 2026
OrthoTrophix, Inc. partners with American Regent, Inc. on TPX-100, a DMOAD candidate, for the United States market, while OrthoTrophix, Inc. retains rights for the rest of the world.
- attends_eventNov 9, 2026
OrthoTrophix, Inc. attends ACR Convergence 2026 in Florida on Nov 9th '26 and presents data from two posters on TPX-100, meniscal pathology, and structural progression in knee osteoarthritis.
For institutional investors. Book with your work email.
OrthoTrophix, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OrthoTrophix, Inc.'s valuation, stock price, and market status.
Is OrthoTrophix, Inc. a public or private company?
OrthoTrophix, Inc. is a private company.
What is the current stock price of OrthoTrophix, Inc.?
OrthoTrophix, Inc. is a private company, so its shares have no public market price. Caplight tracks OrthoTrophix, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OrthoTrophix, Inc. worth (valuation)?
Valuation information for OrthoTrophix, Inc. is not publicly available.
Can I buy OrthoTrophix, Inc. stock?
OrthoTrophix, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OrthoTrophix, Inc.'s last funding round?
OrthoTrophix, Inc.'s most recent funding round was VC Round on December 16, 2016.
Who are the main investors in OrthoTrophix, Inc.?
Investor information for OrthoTrophix, Inc. is not publicly disclosed.
Will OrthoTrophix, Inc. IPO soon?
No public IPO plans have been announced for OrthoTrophix, Inc..
How can I track OrthoTrophix, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in OrthoTrophix, Inc.'s shares on secondary markets.